Craigakess: It is somewhat irresponsible to state that NP is a loudmouth fool and only full of empty promises before allowing the situation to play out. Yes, some of his statements have not come true, but others have and leronlimab is on the verge of approval. Also, if you’ve invested in biotechs before, the delays with leronlimab and over zealous promises from NP are very common. Why? The FDA. The government will always draw a process out, even when the majority of process is not their’s to draw out.

No reason to tar and farther NP until we get more information and let the FDA approval process for leronlimab to run its course.